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Background: Zea mays is used in Ibibio traditional medicine in Nigeria for the treatment of various ailments such as 
pains, malaria and hemorrhoids.  
Objective: To evaluate the anti-inflammatory and analgesic activities of Zea mays ethanol root root extract in mice.  
Methodology: The crude ethanolic extract (45 – 135 mg/kg) of Zea mays root was investigated for anti-inflammatory 
and analgesic activities in mice using various experimental models; acetic acid and thermal- induced pains and 
carrageenan, egg albumin and xylene – induced oedema. The activity of the extract was compared to that of standard 
drug, acetyl salicylic acid (100 mg/kg).   
Results: The extract caused a significant (p<0.05 – 0.001) dose-dependent reduction of inflammation and pains 
induced by different phlogistic agents used. These effects were comparable to that of the standard drugs, acetyl 
salicylic acid (100 mg/kg) used in some models.  
Conclusion: The anti-inflammatory and analgesic effects of this plant may in part be mediated through the chemical 
constituents of the plant and the results of the analgesic action suggest central and peripheral mechanisms. The 
findings of this work confirm the ethno medical use of this plant to treat inflammatory conditions.                                                            
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1. Introduction 
Zea mays L. (Family- Poacae) known as maize or corn, is 
an annual grass plant cultivated for human 
consumption and rearing of animals. It was introduced 
to Nigeria in the 16th century (Osagie and Eka, 1998). It 
is tall with strong erect stalks and a fibrous root system. 
The plant has long narrow leaves that are spaced 
alternately on opposite side of the stem and bears ears 
that are enclosed in modified leaves known as husks 
(Simmonds, 1979).   
Besides its nutritive values, maize grains, leaves, 
cornsilks, stalk, and inflorescence are also used in 
ethnomedicine for the treatment of several ailments. 
The corn silk is used as an antidiabetic or diuretic, and 
decoction of the silk is consumed for the treatment of 
urinary troubles and gallstones (Foster and Duke, 1990; 
Gill, 1992; Abo et al, 2008). The ash of the cob is used 
for the treatment of cough (Gill, 1992) as well as 
inflammatory diseases. The husks are used in the 
treatment of pains and arthritis (Owoyele et al, 2010). it 
is also taken as warm tea for the treatment of malaria in 
Ibibio traditional medicine. Biological activities 
reported on the leaf extract include; anticancer 
(Balasubramanian et al, 2014), antioxidant 
(Balasubramanian and Padma, 2012) and antioxidative 
stress (Balasubramanian and Padma, 2013; 
Balasubramanian et al, 2015) activities. 
Antiinflammatory and analgesic activities have been 
reported on the husk extract (Owoyele et al, 2010).  
Eight phenolic compounds (gallic acid, protocatechuic 
acid, chlorogenic acid, cafeic acid, femlic acid, rutin, 
resveratrol, and kaempferol) have also been detected in 
ethanol husk extract of Zea mays (Dong et al, 2014). The 
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antifungal compounds, 6-methoxybenzoxazolinone and 
6,7-dimethoxy benzoxazolinone, were isolated from an 
ethanol extract of Zea mays roots, and (6R)-7,8-dihydro- 
3-oxo-α-ionone and (6R; 9R)-7,8-dihydro-3-oxo- α -
ionol were isolated from the root exudates (Park et al, 
2004). 
Information on the biological activities of the root 
extract is scarce. We report in this study the anti-
inflammatory and antinociceptive activities of root 
extract of Zea mays to confirm and support its use in 
Ibibio ethnomedicine. 
2. Materials and Methods 
2.1 Plants collection 
The plant material Zea mays (roots) were collected in a 
farmland in Uyo area, Akwa Ibom State, Nigeria in May, 
2015. The plant was identified and authenticated by a 
Taxonomist in the Department of Botany and Ecological 
Studies, University of Uyo, Uyo, Nigeria.   Hebarium 
specimen (DPNH 866) was deposited at Department of 
Pharmacognosy and Natural Medicine Herbarium. 
2.2 Extraction 
The plant parts were washed and shade-dried for two 
weeks. The dried plants’ materials were reduced to 
powder using mortar and pestle. The powdered 
material was soaked in 50% ethanol for 72 hours. The 
liquid filtrate was concentrated and evaporated to 
dryness in vacuo 40°C using rotary evaporator and 
stored in a refrigerator at - 4°C.  
2.3 Phytochemical Screening 
Phytochemical screening of the crude extract was 
carried out employing standard procedures and tests 
(Trease and Evans, 1989; Sofowora, 1993), to reveal the 
presence of chemical constituents such as alkaloids, 
flavonoids, tannins, terpenes, saponins, anthraquinones, 
reducing sugars, cardiac glycosides among others. 
2.4 Animals 
Albino Swiss mice (17-25g) of either sex were obtained 
from the University of Uyo animal house.  They were 
maintained on standard animal pellets and water ad 
libitum. Permission and approval for animal studies 
were obtained from the College of Health Sciences 
Animal Ethics committee, University of Uyo. 
2.5 Determination of median lethal dose (LD50)                      
The median lethal dose (LD50) of the extract was 
estimated using albino mice by intraperitoneal (i.p) 
route using the method of Lorke (1983). This involved 
intraperitoneal administration of different doses of the 
extract (100, 300, 400, 500, 600 and 1000 mg/kg) to 
groups of three mice each. The animals were observed 
for manifestation of physical signs of toxicity such as 
writhing, decreased motor activity, decreased 
body/limb tone, decreased respiration and death. The 
number of deaths in each group within 24 hours was 
recorded.  
The LD50 was calculated as geometrical means of the 
maximum dose producing 0% (a) and the minimum 
dose producing 100% mortality (b): 
 LD50 =√ab 
2.6 Evaluation of antiinflammatory activity of the 
extract 
Carrageenan – induced mice hind paw oedema 
Adult albino male mice were used after 24 hours fast 
and deprived of water only during experiment. 
Inflammation of the hind paw was induced by injection 
of 0.1 ml of freshly prepared carrageenan suspension 
(1%) in normal saline into the sub planar surface of the 
hind paw. The linear circumference of the injected paw 
was measured before and 0.5, 1, 2, 3, 4 and 5 hrs after 
administration of carrageenan. The increase in paw 
circumference post administration of carrageenan was 
adopted as the parameter for measuring inflammation 
(Winter et al, 1962; Akah and Nwambie, 1994; Ekpendu 
et al, 1994, Besra et al, 1996; Nwafor et al, 2010).  The 
difference in paw circumference between the control 
and 0.5, 1, 2, 3, 4 and 5 hrs after administration of 
phlogistic agent was used to assess inflammation (Hess 
and Milonig, 1992).  
The extract (45, 90 and 135 mg/kg i.p) was 
administered to various groups of 6 mice each, 1 h 
before inducing inflammation. Control mice received 10 
ml/kg of distilled water while reference group received 
ASA (100 mg/kg). The average (mean) oedema was 
assessed by measuring with Vernier calipers. Average 
inflammation/oedema (Ct – C0) was calculated for each 
dose (Oriowo, 1982; Akah and Njike, 1990). 
Egg-albumin induced inflammation 
Inflammation was induced in mice by the injection of 
egg albumin (0.1ml, 1% in normal saline) into the sub 
planar tissue of the right hind paw (Akah and Nwambie, 
1994; Okokon and Nwafor, 2010). The linear 
circumference of the injected paw was measured before 
and 0.5, 1, 2, 3, 4 and 5 hrs after the administration of 
the egg albumin. The root extract (45, 90 and 135 
mg/kg i.p) and ASA (100 mg/kg orally) were 
administered to groups (n=6) of 24 h fasted mice 1 h 
before the induction of inflammation. Control group 
received 10 ml/kg of distilled water orally. Edema 
(inflammation) was assessed as the difference in paw 
circumference between the control and 0.5, 1, 2, 3, 4 
and 5 hrs post administration of the egg albumin (Hess 
and Milonig, 1972). The average (mean) edema was 
assessed by measuring with vernier calipers. Average 
inflammation/oedema (Ct – C0) was calculated for each 
dose (Oriowo, 1982; Akah and Njike, 1990). 
Xylene – induced ear oedema 
Inflammation was induced in mice by topical 
administration of 2 drops of xylene at the inner surface 
of the right ear. The xylene was left to act for 15 mins. 
Zea mays root extract (45, 90 and 135 mg/kg i.p), 
dexamethasone (4 mg/kg) and distilled water (0.2 
ml/kg) were orally administered to various groups 
(n=6) of mice 1 h before the induction of inflammation. 
The animals were sacrificed under light anaesthesia and 
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the left ears cut off. The difference between the ear 
weights was taken as the oedema induced by the xylene 
(Tjolsen et al, 1992; Okokon and Nwafor, 2010). 
2.7 Evaluation of analgesic potential of the extract  
Acetic acid induced writhing in mice 
Writhings (abdominal constrictions consisting of the 
contraction of abdominal muscles together with the 
stretching of hindlimbs) resulting from intraperitoneal 
(i.p) injection of 2% acetic acid, was induced according 
to the procedure described by Santos et al. (1994), 
Correa et al. (1996) and Nwafor et al, (2010). The 
animals were divided into 5 groups of 6 mice per group. 
Group 1 served as negative control and received 10 
ml/kg of normal saline, while groups 2, 3 and 4 were 
pre-treated with 45, 90,  and 135 mg/kg  doses of Z. 
mays extract intraperitoneally, and group 5 received 
100 mg/kg of acetyl salicylic acid. After 30 minutes, 0.2 
ml of 2% acetic acid was administered intraperitoneally 
(i.p). The number of writhing movements was counted 
for 30 minutes. Antinociception (analgesia) was 
expressed as the reduction of the number of abdominal 
constrictions between control animals and mice 
pretreated with extracts. 
Thermally induced pain in mice 
The effect of extract on hot plate induced pain was 
investigated in adult mice. The hot plate was used to 
measure the response latencies according to the 
method of Vaz et al, (1996) and Okokon and Nwafor, 
(2010). In these experiments, the hot plate was 
maintained at 45±1oC, each animal was placed into a 
glass beaker of 50 cm diameter on the heated surface, 
and the time(s) between placement and shaking or 
licking of the paws or jumping was recorded as the 
index of response latency. An automatic 30-second cut-
off was used to prevent tissue damage. The animals 
were randomly divided into 5 groups of 6 mice each and 
fasted for 24 hours but allowed access to water. Group 1 
animal served as negative control and received 10 
ml/kg of normal saline. Groups 2, 3 and 4 were pre-
treated intraperitoneally with 45, 90,  and 135 mg/kg 
doses of Z. mays root extract respectively, while group 5 
animals  received 100 mg/kg of acetyl salicylic acid 
intraperitoneally, 30 minutes prior to the placement on 
the hot plate.  
2.8 Statistical analysis and data evaluation 
Data obtained from this work were analyzed 
statistically using Student’s t-test and ANOVA (One- 
way) followed by a  post test (Tukey-Kramer multiple 
comparison  test). Differences between means were 
considered significant at 1% and 5% level of 
significance i.e. P ≤ 0.01 and 0.05. 
3.  Results  
3.1 Phytochemical screening 
The phytochemical screening of the ethanolic extract of 
the root of Zea mays revealed the presence of alkaloids, 
cardiac glycosides, tannins, saponins, terpenes and 
flavonoids.  
3.2 Determination of median lethal dose (LD50) 
The various doses employed in the study produced 
different degrees of mortality (Table 1). The median 
lethal dose (LD50) was calculated to be 447.21 mg/kg. 
The physical signs of toxicity included excitation, paw 
licking, increased respiratory rate, decreased motor 
activity, gasping and coma which was followed by 
death. 
Table 1: Acute toxicity profile of ethanolic root extract 
of Zea mays 
Doses (mg/kg) Mortality 
100 0/3 
300 0/3 
400 0/3 
500 3/3 
1000 3/3 
 
3.3 Carrageenan-induced oedema in mice 
The effect of ethanol extract of Zea mays root on 
carrageenan-induced oedema is as shown in Table 2. 
The extract (45 - 135 mg/kg) exerted a significant 
(P<0.05 – 0.001) anti-inflammatory effect in a dose –
dependent manner at the later phase (3-5h). The 
activity of the highest dose was more than that of the 
standard drug, ASA, 100 mg/kg (Table 2).  
 
Table 2: Effect of Zea mays root extract on carrageenan induced oedema in rats. 
Treatment 
Linear circumference of injected paw (mm) ± SEM 
0.5hr 1hr 2hr 3hr 4hr 5hr 
Control  1.53 ± 0.22 1.55 ± 0.23 2.66 ± 0.12 2.55 ± 0.13 2.55 ± 0.19 2.10 ± 0.26 
Extract 
45 mg/kg 
 
1.64± 0.28 
 
1.81 ± 0.61 
 
1.96 ± 0.25 
 
1.75 ± 0.31 
 
1.59 ± 0.30a 
 
1.38 ± 0.33  
90 mg/kg 1.99± 0.22 2.22 ± 0.166 2.34 ± 0.05 1.62 ± 0.15a 1.48 ± 0.13a 1.27 ± 0.14c  
135 mg/kg 1.77 ± 0.20 1.76 ± 0.14 2.39 ± 0.08 1.56 ± 0.15a 1.43 ± 0.21b 0.85 ± 0.16C 
ASA 100 mg/kg 1.58±0.21 1.42 ± 0.80 1.63 ± 0.37a 1.48 ± 0.33a 1.22 ± 0.08b 1.22 ± 0.29C 
Data are expressed as mean ± SEM.  Significant at a P<0.05, b P < 0.01, c P < 0.001 when compared to control. n = 6 
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Table 3: Effect of Zea mays root extract on egg-albumin induced oedema in rats. 
Treatment 
Linear circumference of injected paw (mm) ± SEM 
0.5hr 1hr 2hr 3hr 4hr 5hr 
Control 3.43 ± 0.14 3.58 ± 0.10 3.44  ± 0.11 3.27  ± 0.14 3.23 ± 0.17 2.72 ± 0.06 
Extract 
45 mg/kg 
 
3.18 ±0.12 
 
3.05 ± 0.11 
 
3.16 ± 0.11 
 
2.61 ± 0.18 
 
2.52 ± 0.13 
 
1.97 ± 0.10  
90 mg/kg 3.38 ±0.12 3.40 ± 0.20 3.34 ± 0.20 3.08 ± 0.27 2.61 ± 0.19c 2.33 ± 0.24  
135 mg/kg 2.35± 0.53a 2.22 ± 0.29c 2.18 ± 0.30c 1.91  ± 0.25c 1.62 ± 0.33 c 1.68 ± 0.41 c 
ASA 100 mg/kg 3.33 ±0.07 2.78 ± 0.05a 2.56 ± 0.06a 2.37± 0.01a 2.02 ± 0.04b 1.60 ± 0.12a 
Data are expressed as mean ± SEM.  Significant at a P<0.05, b P < 0.01, c P < 0.001 when compared to control. n = 6 
Table 4: Effect of Zea mays root extract on xylene-induced ear oedema in mice. 
Treatment Weight of right ear (g) Weight of left ear (g) Increase in ear weight (g) % Inhibition 
Control  0.053 ± 0.003 0.110 ± 0.005 (105.66) 0.056 ± 0.006  
Extract 
45 mg/kg 
 
0.053 ± 0.003 
 
0.090 ± 0.00 
 
(67.92) 0.036 ± 0.003a 
 
35.71 
90 mg/kg 0.053 ± 0.003 0.080 ± 0.005 (49.05) 0.026 ± 0.003b 53.57 
135 mg/kg 0.056± 0.003 0.070 ± 0.005 (35.71) 0.020 ± 0.00c 64.28 
Dexamethasone 
4.0 mg/kg 
0.053 ± 0.003 0.060 ± 0.003 (24.52) 0.013 ± 0.003c 76.78 
Figures in parenthesis indicate % increase in ear weight. Significant at a P<0.05, b P < 0.01, c P < 0.001 when compared to control. n 
= 6 
3.4 Egg albumin- induced oedema  
Administration of extract of Zea mays (45 - 135 mg/kg) 
on egg albumin - induced oedema in mice caused a 
significant (p<0.05 – 0.001) dose-dependent anti-
inflammatory effect against oedema caused by egg 
albumin at the later phase (3 - 5h).  The effect was weak 
compared to that of standard drug, ASA (100 mg/kg) 
(Table 3). 
3.5 Xylene- induced ear edema 
Anti-inflammatory effect of crude extract of Zea mays 
against xylene-induced ear oedema in mice is shown in 
Table 4. The extract exerted a dose-dependent anti-
inflammatory effects that were significant (P<0.05 - 
0.01) but weak compared to that of the standard drug, 
dexamethasone (4.0 mg/kg). 
3.6 Effect of ethanol crude extract of Z. mays on 
acetic acid-induced writhing in mice 
The administration of Zea mays extract (45 - 135 
mg/kg) demonstrated a dose-dependent reduction in 
acetic acid-induced writhing in mice. The reductions 
were statistically significant (p<0.05 - 0.001) relative to 
control and the effect of the highest dose (135 mg/kg) 
at 30 min was ccomparable to that of the standard drug, 
ASA (Table 5). 
3.7 Effect of ethanol root extract of Z. mays on 
thermally-induced pain in mice. 
The extract (45 - 135 mg/kg) exhibited a dose - 
dependent effect on thermally-induced pain in mice. 
This inhibitions were statistically significant (p<0.001) 
relative to the control but weak compared to that of the 
standard drug, ASA (100 mg/kg) (Table  6). 
Table 5: Effect of Zea mays root extract on acetic acid induced writhing in mice. 
Treatment 
Time intervals (hr) 
5 10 15 20 25 30 Total 
Control 6.66 ± 0.88 11.66 ± 1.20 24.66 ± 1.85 17.0 ± 0.57 13.00 ± 1.15 11.0 ± 1.00 83.98 ± 6.65 
Extract 
45 mg/kg 
 
4.33 ± 0.33 
 
5.33 ± 1.45 
 
13.0 ± 2.00b 
 
12.66 ± 0.88b  
 
11.66 ± 0.66  
 
7.66 ± 0.33  
 
54.64 ± 5.65a 
90 mg/kg 3.33 ± 0.33 5.33 ± 2.96  9.00 ± 1.52c 9.66 ± 0.88c 8.33 ± 1.76 7.0 ± 1.00a 42.65 ± 8.45c 
135 mg/kg 0.33 ± 0.33c 3.00 ± 0.57b 4.33 ± 1.20c 4.00 ± 0.57c 5.66 ± 0.88b 4.00 ± 0.57c 21.32 ± 4.12c 
ASA 100 mg/kg 4.00 ± 0.57a 6.00 ± 0.57 8.33 ± 0.88c 8.66 ± 0.33c 7.66 ± 0.66c 4.00 ± 0.57c  38.65 ± 3.58c 
Data are expressed as mean ± SEM.  Significant at a P<0.05, b P < 0.01, c P < 0.001 when compared to control. n = 6 
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Table 6: Effect of Zea mays root extract on hot plate test 
Treatment 
Reaction time (sec) 
(mean ± SEM) 
% inhibition 
Control 4.92 ± 0.23  
Extract 
45 mg/kg 
5.97 ± 0.22 21.34 
90 mg/kg 13.25 ± 0.50 a 169.30 
135 mg/kg 20.51 ± 0.74c 316.86 
ASA 100 mg/kg 29.53 ± 3.48c 500.20 
Data are expressed as mean ± SEM.  n = 6. 
Significant at aP < 0.05, b P < 0.001, c P < 0.001 when compared to control.  
4. Discussion 
Zea mays root is used traditionally for the treatment of 
various illnesses such as malarial fever, pains and 
inflammatory conditions. In this study, the ethanol root 
extract was evaluated for analgesic and anti-
inflammatory activities using different experimental 
models. 
In the carrageenan-induced oedema, the extract (45- 
135 mg/kg) was observed to have exerted significant 
effect at the later stage of inflammation (3-5 hr) 
indicating insignificant effect on histamine, serotonin 
and kinins that are involved in the early stage of 
carrageenan-induced oedema (Vane and Booting, 
1987). The extract caused significant reduction of the 
later stage of the oedema maybe due to its ability to 
inhibit prostaglandin which is known to mediate the 
second phase of carrageenan-induced inflammation 
(Vane and Booting, 1987). However, ASA (100 mg/kg) a 
prototype NSAID, a cyclooxygenase inhibitor whose 
mechanism of action involves inhibition of 
prostaglandin, produced a considerable inhibition of the 
paw swelling induced by carrageenan injection. 
The extract also inhibited egg albumin-induced oedema, 
though at the later stage (3-5hr), demonstrating that it 
can inhibit inflammation by blocking the release of 
histamine and 5-HT, two mediators that are released by 
egg albumin (Nwafor et al, 2007). However, ASA, a 
cyclooxygenase inhibitor reduced significantly oedema 
produced by egg albumin. 
The  extract exerted a significant (p<0.01) inhibition of 
ear oedema caused by xylene only at all doses of the 
extract, suggesting the inhibition of phospholipase A2 
which is involve in the pathophysiology of inflammation 
due to xylene (Lin et al,1992). However, 
dexamethasone, a steroid antiinflammatory agent 
produced significant reduction in the mean right ear 
weight of positive control rats indicating an inhibition 
of PLA2. 
The extract significantly reduced acetic acid-induced 
writhing and delayed the reaction time of animals 
(mice) to thermally induced pain. Acetic acid causes 
inflammatory pain by inducing capillary permeability 
(Amico-Roxas et  al.,1984;  Nwafor et  al., 2007), and in 
part through local peritoneal receptors  from peritoneal 
fluid concentration of PGE2 and PGF2α (Deraedt et 
al,1980;  Bentley et al,1983). The acetic acid-induced 
abdominal writhing is a visceral pain model in which 
the processor releases arachidonic acid via 
cyclooxygenase, and prostaglandin biosynthesis plays a 
role in the nociceptive mechanism (Franzotti et al, 
2002). It is used to distinguish between central and 
peripheral pain. These results suggest that the extract 
may be exerting its action partly through the 
lipoxygenase and/or cyclooxygenase system.  
The study also shows that the extract significantly 
delayed the reaction time of thermally- induced (hot 
plate) test. This model is selective for centrally acting 
analgesics and indicates narcotic involvement (Turner, 
1995) with opioid receptors. 
Phytochemical screening of the root extract revealed 
the presence of alkaloids, cardiac glycosides, tannins, 
saponins, terpenes and flavonoids. Flavonoids are 
known anti-inflammatory compounds acting through 
inhibition of the cyclo-oxygenase pathway (Liang et al, 
1999). Some flavonoids are reported to block both the 
cyclooxygenase and lipoxygenase pathways of the 
arachidonate cascade at relatively high concentrations, 
while at lower concentrations they only block 
lipoxygenase pathway (Carlo et al, 1999). Some 
flavonoids exert their antinociception via opioid 
receptor activation activity (Suh et al, 1996; Rajendran 
et al, 2000; Otuki et al, 2005). Flavonoids also exhibit 
inhibitory effects against phospholipase A2 and 
phospholipase C (Middleton et al, 2000), and 
cyclooxygenase and/or lipoxygenase pathways (Robak 
et al, 1998). 
Triterpenes have been implicated in anti-inflammatory 
activity of plants (Huss et al, 2002; Suh et al, 1998) and 
reports on their analgesic activities have also been 
published (Liu, 1995; Krogh et al, 1999; Tapondjou et al, 
2003; Maia et al, 2006). Ursolic acid is a selective 
inhibitor of cyclooxygenase-2 (Ringbom et al, 1998).  
Oleanolic acid is known to exert its analgesic action 
through an opioid mechanism, and possibly, a 
modulatory influence on vanilliod receptors (Maia et al, 
2006). 
5. Conclusion 
The results of this study demonstrated that Zea mays 
root possesses analgesic property. Further investigation 
is being advocated especially in elucidating cellular 
mechanisms and establishing structural components of 
the active ingredients with a view of standardizing 
them. 
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